MedTrace Logo

An Exploratory Study to Evaluate the Tolerability and Safety of MWAV201 in Subjects With Wilson Disease

NCT06663878 · Status: NOT_YET_RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2024-10-29

No results posted yet for this study

Summary

The primary objective of this study is to evaluate the tolerability and safety of MWAV201 in patients with Wilson disease.

Conditions

  • Wilson Disease

Interventions

GENETIC

MWAV201

Nonreplicating, recombinant gene transfer vector

Sponsors & Collaborators

  • Mabwell (Shanghai) Bioscience Co., Ltd.

    collaborator INDUSTRY

  • Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

    lead OTHER

Principal Investigators

  • Jian-Gao Fan, doctor · Xinhua Hospital, Shanghai Jiao Tong University School of Medicine

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-10-31
Primary Completion
2026-03-31
Completion
2031-05-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06663878 on ClinicalTrials.gov